ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

ADVFN

Trade Now

EasyMarkets
Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P 500
4,585.59
(
0.8%
)
US Tech 100
15,612.00
(
1.36%
)
Dow Jones
36,117.38
(
0.17%
)
Brent Oil
75.595
(
1.29%
)
Bitcoin
43,467.32
(
0.39%
)
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Galmed Pharmaceuticals Ltd (GLMD)

  7. Galmed Pharmaceuticals Ltd (GLMD) News

GLMD Galmed Pharmaceuticals Ltd

0.42
0.025 (6.33%)
Dec 07 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Galmed Pharmaceuticals Ltd GLMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.025 6.33% 0.42 18:58:18
Open Price Low Price High Price Close Price Prev Close
0.395 0.3814 0.4673 0.3959 0.395
more quote information »

Recent News

Date Time Source Heading
11/30/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
11/22/202316:48EDGAR2Form POS AM - Post-Effective amendments for registration..
11/20/202316:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/20/202316:32PRNUSGalmed Announces a delay in the initiation of its Primary..
11/01/202316:15EDGAR2Form POS AM - Post-Effective amendments for registration..
9/26/202308:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/26/202308:30PRNUSGalmed Announces Allowance of New Patent for Aramchol for..
9/22/202316:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/22/202316:05PRNUSGalmed Pharmaceuticals Announces Receipt of Nasdaq Minimum..
9/21/202307:30EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
9/20/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/13/202316:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/09/202316:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/09/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/02/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/21/202310:12EDGAR2Form SC 13G - Statement of acquisition of beneficial..
7/18/202309:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/18/202309:23EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
7/14/202309:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/14/202309:30PRNUSGalmed Pharmaceuticals Announces Pricing of $7 Million..
7/13/202317:08EDGAR2Form F-1/A - Registration statement for certain foreign..
7/12/202317:29EDGAR2Form F-1/A - Registration statement for certain foreign..
7/10/202308:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/10/202308:00PRNUSGalmed to employ OnKai's disruptive Artificial Intelligence..
6/28/202308:40EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
6/28/202308:37EDGAR2Form F-1/A - Registration statement for certain foreign..
6/01/202308:00PRNUSGalmed Pharmaceuticals Reports First Quarter 2023 Financial..
5/09/202307:00PRNUSGalmed Announces Initiation of a Clinical Development..
3/29/202317:00PRNUSGalmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F..
2/08/202308:00PRNUSGalmed Announces Issuance of New Composition of Matter..
1/04/202308:00PRNUSGalmed reports results from the Open-Label part of the ARMOR..
12/14/202217:00PRNUSGalmed Pharmaceuticals Ltd. (NASDAQ: GLMD) Announces Receipt..

Your Recent History

NASDAQ
GLMD
Galmed Pharmaceuticals
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com